Green Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	13,407	9,068	6,348	2,814	3,388
Short-Term Investments	25.46	127.56	5,669	2,300	7,800
Trading Asset Securities	3,754	3,690	2,436	11,835	5,015
Cash & Short-Term Investments	17,186	12,885	14,453	16,949	16,203
Cash Growth	33.38%	-10.85%	-14.73%	4.60%	7.08%
Accounts Receivable	6,893	4,997	1,451	2,509	3,450
Other Receivables	35.99	38.99	8.54	333.75	114.13
Receivables	6,929	5,036	1,460	2,843	3,564
Inventory	8,418	3,905	5,311	6,014	5,732
Prepaid Expenses	49.49	52.01	160.15	42.62	735.77
Other Current Assets	94.51	112.3	328.73	595.04	657.55
Total Current Assets	32,678	21,991	21,712	26,443	26,892
Property, Plant & Equipment	12,560	13,533	13,256	27,112	36,846
Long-Term Investments	-	-	-	-	7,381
Other Intangible Assets	94.74	97.47	2.81	87.92	181.72
Long-Term Deferred Tax Assets	-	-	-	-	619.37
Long-Term Deferred Charges	170.68	11.92	24.91	-	-
Other Long-Term Assets	9,361	9,339	8,833	8,788	57.44
Total Assets	54,864	44,972	43,828	62,432	71,977
Accounts Payable	7,610	2,151	-	-	4,114
Accrued Expenses	37.76	5.62	-	-	2.12
Short-Term Debt	6,500	4,800	4,800	6,488	7,433
Current Portion of Leases	124.18	41.01	104.04	117.85	104.86
Current Unearned Revenue	26.1	46.72	34	34	-
Other Current Liabilities	1,713	1,270	2,455	2,796	3,588
Total Current Liabilities	16,011	8,314	7,394	9,437	15,242
Long-Term Leases	367.99	530.9	28.82	18.27	57.76
Pension & Post-Retirement Benefits	146.95	357.51	443.95	331.2	371.39
Other Long-Term Liabilities	50.34	21.61	8.12	6.78	8.19
Total Liabilities	16,576	9,224	7,874	9,793	15,679
Common Stock	10,000	10,000	10,000	7,500	7,500
Additional Paid-In Capital	15,777	15,025	36,425	38,956	38,956
Retained Earnings	12,871	12,746	-10,105	6,232	9,680
Treasury Stock	-360.3	-2,023	-366.29	-	-
Comprehensive Income & Other	-0	-0	0	-48.7	162.39
Shareholders' Equity	38,288	35,748	35,954	52,639	56,298
Total Liabilities & Equity	54,864	44,972	43,828	62,432	71,977
Total Debt	6,992	5,372	4,933	6,624	7,595
Net Cash (Debt)	10,194	7,513	9,520	10,324	8,608
Net Cash Growth	35.68%	-21.08%	-7.79%	19.93%	-1.28%
Net Cash Per Share	531.08	390.48	476.93	516.22	430.42
Filing Date Shares Outstanding	19.84	19.09	19.83	20	20
Total Common Shares Outstanding	19.84	19.09	19.83	20	20
Working Capital	16,667	13,677	14,319	17,007	11,651
Book Value Per Share	1930.08	1872.83	1812.66	2631.95	2814.92
Tangible Book Value	38,193	35,650	35,951	52,551	56,117
Tangible Book Value Per Share	1925.30	1867.72	1812.52	2627.55	2805.83
Land	8,450	8,450	8,425	8,329	7,923
Buildings	7,081	7,918	7,846	16,077	13,381
Machinery	35,863	35,677	35,434	38,766	39,913
Construction In Progress	332.16	-	23.1	207.03	11,769

Source: S&P Global Market Intelligence. Standard template. Financial Sources.